The human gluteus maximus muscle (GMX) is characterised by its insertion to the iliotibial tract (a lateral thick fascia of the thigh beneath the fascia lata), which plays a critical role in lateral stabilisation of the hip joint during walking. In contrast, in non-human primates, the GMX and biceps femoris muscle provide a flexor complex. According to our observations of 15 human embryos and 11 foetuses at 7-10 weeks of gestation (21-55 mm), the GMX anlage was divided into 1) a superior part that developed earlier and 2) a small inferior part that developed later. The latter was adjacent to, or even continuous with, the biceps femoris. At 8 weeks, both parts inserted into the femur, possibly the future gluteal tuberosity. However, depending on traction by the developing inferior part as well as pressure from the developing major trochanter of the femur, most of the original femoral insertion of the GMX appeared to be detached from the femur. Therefore, at 9-10 weeks, the GMX had a digastric muscle-like appearance with an intermediate band connecting the major superior part to the small inferior mass. This band, most likely corresponding to the initial iliotibial tract, extended laterally and distally far from the muscle fibres. The fascia lata was still thin and the tensor fasciae latae seemed to develop much later. It seems likely that the evolutionary transition from quadripedality to bipedality and a permanently upright posture would require the development of a new GMX complex with the iliotibial tract that differs from that in non-human primates. (Folia Morphol 2018; 77, 1: 144-150).
To examine a common plantar tendinous plate for long flexors of the toe and fingers in human embryos, we observed sections of 10 embryos at 5-6 weeks (crown-rump length or CRL 15-21 mm). The heel or tuber of the calcaneus was underdeveloped in 3 embryos with CRL 15 mm and the talus appeared not to be piled up on the calcaneus but these two bones were arranged along the lateromedial axis. As reported in the hand, we demonstrated, in the deep side of tarsal bones, a common tendinous plate formed by a joining of the flexor halluces longus and flexor digitorum longus tendons. In the tendinous plate, much or less, some connections between tendons seemed to remain even after birth to provide much greater types of tendon anomalies than in the hand. In addition, we postulated a hypothetical change in course of the peroneus longus tendon. In the initial phase, because of the underdeveloped calcaneus, the peroneus tendon might take an almost straight course similar to long flexor tendons. However, at 6 weeks and later, the inferomedially expanding calcaneus beneath the talus was likely to push the tendon to the cuboid bone.
Patient:A 73-year-old woman presented with the chief complaint of esthetic and chewing problems because of unstable dentures on both maxilla and mandibular, and right tongue sub-total extirpation. We made a treatment denture, which basically aimed at increased mouth volume and restore facial image to improve function. This resulted in improved stability of denture, oral muscles and bite.Discussion: Using the treatment denture, the volume of the mouth was recovered and it is thought that the form harmonizes with the oral muscles and the tongue. The form is not only to be derived but also extracts the maximum function. Conclusion: Using the treatment denture, the patient has regained oral function and progress has been satisfactory, even though, the patient has both less ridge and right tongue sub-total extirpation.
Key wordsmouth volume, treatment denture, form of polished surface, fl at table, functional impression registration 98 99
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.